FI870100A0 - Förfarande för framställning av terapeutiskt aktiva 2-(substituerad amino)bens/cd/indolderivat - Google Patents
Förfarande för framställning av terapeutiskt aktiva 2-(substituerad amino)bens/cd/indolderivatInfo
- Publication number
- FI870100A0 FI870100A0 FI870100A FI870100A FI870100A0 FI 870100 A0 FI870100 A0 FI 870100A0 FI 870100 A FI870100 A FI 870100A FI 870100 A FI870100 A FI 870100A FI 870100 A0 FI870100 A0 FI 870100A0
- Authority
- FI
- Finland
- Prior art keywords
- benz
- preparation
- substituted amino
- therapeutically active
- indole derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Heart & Thoracic Surgery (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Cardiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyridine Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US81831586 | 1986-01-13 | ||
| US06/818,315 US4728663A (en) | 1986-01-13 | 1986-01-13 | N-[(1H-imidazol-1-yl)alkyl]benz[cd]-indol-2-amines and use in inhibiting thromboxane synthetase enzyme |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| FI870100A0 true FI870100A0 (sv) | 1987-01-12 |
| FI870100A FI870100A (sv) | 1987-07-14 |
| FI92063B FI92063B (sv) | 1994-06-15 |
| FI92063C FI92063C (sv) | 1994-09-26 |
Family
ID=25225236
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI870100A FI92063C (sv) | 1986-01-13 | 1987-01-12 | Förfarande för framställning av terapeutiskt aktiva 2-(substituerad amino)bens/cd/indolderivat |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US4728663A (sv) |
| EP (1) | EP0230035B1 (sv) |
| JP (1) | JPS62215582A (sv) |
| KR (1) | KR900002756B1 (sv) |
| AT (1) | ATE112771T1 (sv) |
| AU (1) | AU604223B2 (sv) |
| CA (1) | CA1317948C (sv) |
| DE (1) | DE3650096D1 (sv) |
| DK (1) | DK12487A (sv) |
| FI (1) | FI92063C (sv) |
| HU (1) | HU198924B (sv) |
| NO (1) | NO168035C (sv) |
| NZ (1) | NZ218879A (sv) |
| PH (1) | PH23606A (sv) |
| ZA (1) | ZA87185B (sv) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5081131A (en) * | 1986-01-13 | 1992-01-14 | American Cyanamid Company | Omega-((hetero)alkyl)benz(cd)-indol-2-amines |
| IT1229237B (it) * | 1989-05-08 | 1991-07-26 | Prodotti Formenti | Sali di (2-(piridil)etil) metilammina |
| US5079247A (en) * | 1990-03-14 | 1992-01-07 | American Cyanamid Company | N1 -substituted benz(cd)indol-2-imine compounds as cardiovascular agents |
| GB9127304D0 (en) * | 1991-12-23 | 1992-02-19 | Boots Co Plc | Therapeutic agents |
| GB9312893D0 (en) * | 1993-06-22 | 1993-08-04 | Boots Co Plc | Therapeutic agents |
| DE19628893A1 (de) * | 1996-07-17 | 1998-01-22 | Basf Ag | Verwendung von 1-Amidoalkylimidazolen als Korrosionsinhibitoren in der petrochemischen Industrie und Verfahren zu deren Herstellung |
| US6077460A (en) * | 1996-07-17 | 2000-06-20 | Basf Aktiengesellschaft | Corrosion inhibition |
| CA2317572A1 (en) | 1998-04-02 | 1999-10-14 | Jared Miller Wagner | Pharmaceutical compositions and methods for use |
| US20010031771A1 (en) | 1999-05-24 | 2001-10-18 | Gary Maurice Dull | Pharmaceutical compositions and methods for use |
| US6403581B1 (en) | 2000-01-19 | 2002-06-11 | American Cyanamid Company | Method of inhibition of farnesyl-protein transferase using substituted benz (cd) indol-2-imine and-amine derivatives |
| CN111662226B (zh) * | 2015-01-28 | 2022-03-18 | 中国科学院广州生物医药与健康研究院 | 一种2-氧代-1,2-二氢苯并[cd]吲哚类化合物 |
| CN114349684B (zh) * | 2022-01-19 | 2023-03-28 | 西南林业大学 | 一种苯并[c,d]吲哚亚胺衍生物的合成方法 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR1388599A (fr) * | 1963-04-20 | 1965-02-05 | Bayer Ag | Colorants nouveaux et procédé pour les fabriquer et les appliquer |
| DE2608020A1 (de) * | 1976-02-27 | 1977-09-01 | Bayer Ag | Naphthostyrilfarbstoffe |
| DK335477A (da) * | 1976-08-03 | 1978-02-04 | Sandoz Ag | Fremgangsmaade til fremstilling af benz(cd)indolylderivater |
| US4261896A (en) * | 1979-11-23 | 1981-04-14 | American Cyanamid Company | 1-Substituted-2-(substituted-imino)-1H-1,2-dihydrobenz[cd]indoles |
| US4259490A (en) * | 1980-06-23 | 1981-03-31 | American Cyanamid Company | 2-(Substituted amino)benz[cd]indoles |
-
1986
- 1986-01-13 US US06/818,315 patent/US4728663A/en not_active Expired - Fee Related
- 1986-12-22 AT AT86117878T patent/ATE112771T1/de not_active IP Right Cessation
- 1986-12-22 EP EP86117878A patent/EP0230035B1/en not_active Expired - Lifetime
- 1986-12-22 DE DE3650096T patent/DE3650096D1/de not_active Expired - Lifetime
-
1987
- 1987-01-09 CA CA000527024A patent/CA1317948C/en not_active Expired - Fee Related
- 1987-01-09 NZ NZ218879A patent/NZ218879A/en unknown
- 1987-01-12 ZA ZA87185A patent/ZA87185B/xx unknown
- 1987-01-12 KR KR1019870000168A patent/KR900002756B1/ko not_active IP Right Cessation
- 1987-01-12 HU HU8791A patent/HU198924B/hu not_active IP Right Cessation
- 1987-01-12 NO NO870111A patent/NO168035C/no unknown
- 1987-01-12 DK DK012487A patent/DK12487A/da unknown
- 1987-01-12 FI FI870100A patent/FI92063C/sv not_active IP Right Cessation
- 1987-01-12 AU AU67493/87A patent/AU604223B2/en not_active Ceased
- 1987-01-12 PH PH34708A patent/PH23606A/en unknown
- 1987-01-13 JP JP62004198A patent/JPS62215582A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| FI92063C (sv) | 1994-09-26 |
| NO168035B (no) | 1991-09-30 |
| NO870111L (no) | 1987-07-14 |
| ATE112771T1 (de) | 1994-10-15 |
| HU198924B (en) | 1989-12-28 |
| AU604223B2 (en) | 1990-12-13 |
| AU6749387A (en) | 1987-07-16 |
| NO870111D0 (no) | 1987-01-12 |
| DK12487A (da) | 1987-07-14 |
| CA1317948C (en) | 1993-05-18 |
| DE3650096D1 (de) | 1994-11-17 |
| ZA87185B (en) | 1988-07-27 |
| US4728663A (en) | 1988-03-01 |
| EP0230035A3 (en) | 1990-01-10 |
| HUT43059A (en) | 1987-09-28 |
| PH23606A (en) | 1989-09-11 |
| KR870007158A (ko) | 1987-08-17 |
| NO168035C (no) | 1992-01-08 |
| FI870100A (sv) | 1987-07-14 |
| DK12487D0 (da) | 1987-01-12 |
| EP0230035B1 (en) | 1994-10-12 |
| KR900002756B1 (ko) | 1990-04-28 |
| NZ218879A (en) | 1990-12-21 |
| JPS62215582A (ja) | 1987-09-22 |
| FI92063B (sv) | 1994-06-15 |
| EP0230035A2 (en) | 1987-07-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI870100A0 (sv) | Förfarande för framställning av terapeutiskt aktiva 2-(substituerad amino)bens/cd/indolderivat | |
| NO177387C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive imidazo-kondenserte, 6-leddede, heterocykliske forbindelser | |
| FI95712C (sv) | Förfarande för framställning av inhibitorer för steroid-5- -reduktas | |
| NO180718C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive mercaptoacetylamidderivater | |
| FI92934B (sv) | Analogiförfarande för framställning av terapeutiskt användbara 1-deoxinojirimycinderivat | |
| NO872589D0 (no) | Noeytrale metalloendopeptidaseinhibitorer for behandling av hypertensjon. | |
| NO954490D0 (no) | Analogifremgangsmåte for fremstilling av farmakologisk aktive pyrimidinforbindelser | |
| CA2036618A1 (en) | Fused thiophene derivatives, their production and use | |
| GR900100380A (el) | Μέ?οδος παρασκευής αντι-φλεγμονωδών παραγώγων αμινοφενόλης. | |
| FI97230B (sv) | Förfarande för framställning av terapeutiskt användbara 7-oxabicykloheptylsubstituerade heterocykliska amidprostaglandinderivat | |
| ES8501412A1 (es) | "un metodo para la preparacion de un derivado de aminoacido" | |
| KR920007999A (ko) | 4-또는 5-치환된 피리딘-2-카복실산. 이들의 제조방법 및 약제로서 이들의 용도 | |
| NO176105C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive peptidderivater | |
| FI906084A0 (sv) | Förfarande för framställning av nya terapeutiskt användbara 5-(2-metyl-4,4,4-trifluorbutylkarbamoyl)indolderivat | |
| FI99013B (sv) | Analogiförfarande för framställning av terapeutiskt användbara bensimidazolderivat | |
| GB1433103A (en) | Pharmacologically active pyrrolodiazepines | |
| ES2012958A6 (es) | Procedimiento para preparar derivados de cisteina. | |
| DK0868428T3 (da) | Phosphonsyrederivater med metallopeptidaseinhiberende aktivitet | |
| FI97885B (sv) | Förfarande för framställning av terapeutiskt aktiva nojirimycinderivat | |
| FI960488A0 (sv) | Förfarande för framställning av sackarinderivat användbara som inhibitorer för proteolytiskt enzym | |
| SU1014250A1 (ru) | Гидрохлорид 3-(2-морфолиноэтилтио)-1,2,4-триазино (6,5-b) индола, обладающий противогипоксической и противовоспалительной активностью | |
| ATE50564T1 (de) | Heterocyclische verbindungen. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| BB | Publication of examined application | ||
| MM | Patent lapsed | ||
| MM | Patent lapsed |
Owner name: AMERICAN CYANAMID COMPANY |